About Tapasin
Tapasin (TAPBP) is a protein
from Homo sapiens identified by UniProt accession
O15533, 448 residues long.
MolForge cross-references it against 0 known binders and
136 disease associations.
Target properties
| Protein name | Tapasin |
| UniProt accession | O15533 |
| Gene | TAPBP |
| Organism | Homo sapiens |
| Length | 448 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (136)
Diseases linked to this target (Open Targets).
- Immunodeficiency by defective expression of HLA class 1 · score 0.62
- MHC class I deficiency · score 0.49
- age at menopause · score 0.10
- neoplasm · score 0.09
- malaria · score 0.07
- body mass index · score 0.06
- severe combined immunodeficiency due to CTPS1 deficiency · score 0.05
- immunodeficiency 18 · score 0.05
- severe combined immunodeficiency due to CARD11 deficiency · score 0.05
- reticular dysgenesis · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O15533-F1 | alphafold | PREDICTED | 87.06 | — |
Amino-acid sequence (448 residues)
MKSLSLLLAV ALGLATAVSA GPAVIECWFV EDASGKGLAK RPGALLLRQG PGEPPPRPDL DPELYLSVHD PAGALQAAFR RYPRGAPAPH CEMSRFVPLP ASAKWASGLT PAQNCPRALD GAWLMVSISS PVLSLSSLLR PQPEPQQEPV LITMATVVLT VLTHTPAPRV RLGQDALLDL SFAYMPPTSE AASSLAPGPP PFGLEWRRQH LGKGHLLLAA TPGLNGQMPA AQEGAVAFAA WDDDEPWGPW TGNGTFWLPT VQPFQEGTYL ATIHLPYLQG QVTLELAVYK PPKVSLMPAT LARAAPGEAP PELLCLVSHF YPSGGLEVEW ELRGGPGGRS QKAEGQRWLS ALRHHSDGSV SLSGHLQPPP VTTEQHGARY ACRIHHPSLP ASGRSAEVTL EVAGLSGPSL EDSVGLFLSA FLLLGLFKAL GWAAVYLSTC KDSKKKAE
Explore Tapasin with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets